The calibration and validation results for all cases are included in the Supplementary Information
Using the right strand information, we were not able to replicate the positive-control effect of GLP-1R on T2D using their instruments
Psychiatric safety of semaglutide for weight management in people without known major psychopathology: post hoc analysis of the STEP 1, 2, 3, and 5 trials
Some patients experience a phenomenon called tolerance, where their body gradually becomes less responsive to the medication over time
The FDA label states: "It is unknown whether Wegovy causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans." The boxed warning is reproduced at FDA's accessdata label for Wegovy
sodium-glucose transporter 2 inhibitors Clinical Perspective